Thursday, November 12, 2015

Evaluation of PCV1 as vaccine vector to express antigenic epitopes of PRRSv


 2015 Nov 7. pii: S0168-1702(15)30112-X. doi: 10.1016/j.virusres.2015.11.005. [Epub ahead of print]

Evaluation of the use of non-pathogenic porcine circovirus type 1 as a vaccine delivery virus vector to express antigenic epitopes of porcine reproductive and respiratory syndrome virus.

Author information

  • 1Department of Biomedical Sciences & Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, VA 24060, USA; Department of Veterinary Diagnostic and Production Animal Medicine, Iowa State University College of Veterinary Medicine, Ames, Iowa 5001, USA.
  • 2Department of Biomedical Sciences & Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, VA 24060, USA.
  • 3Department of Veterinary Diagnostic and Production Animal Medicine, Iowa State University College of Veterinary Medicine, Ames, Iowa 5001, USA.
  • 4Department of Veterinary Diagnostic and Production Animal Medicine, Iowa State University College of Veterinary Medicine, Ames, Iowa 5001, USA; The Roslin Institute and The Royal (Dick) School of Veterinary Studies, University of Edinburgh, Edinburgh, United Kingdom.
  • 5Department of Biomedical Sciences & Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, VA 24060, USA. Electronic address: xjmeng@vt.edu.

Abstract

We previously demonstrated that the C-terminus of the capsid gene of porcine circovirus type 2 (PCV2) is an immune reactive epitope displayed on the surface of virions. Insertion of foreign epitope tags in the C-terminus produced infectious virions that elicited humoral immune responses against both PCV2 capsid and the inserted epitope tags, whereas mutation in the N terminus impaired viral replication. Since the non-pathogenic porcine circovirus type 1 (PCV1) shares similar genomic organization and significant sequence identity with pathogenic PCV2, in this study we evaluated whether PCV1 can serve as a vaccine delivery virus vector. Four different antigenic determinants of porcine reproductive and respiratory syndrome virus (PRRSV) were inserted in the C-terminus of the PCV1 capsid gene, the infectivity and immunogenicity of the resulting viruses are determined. We showed that an insertion of 12 (PRRSV-GP2 epitope II, PRRSV-GP3 epitope I, and PRRSV-GP5 epitope I), and 14 (PRRSV-GP5 epitope IV) amino acid residues did not affect PCV1 replication. We successfully rescued and characterized four chimeric PCV1 viruses expressing PRRSV linear antigenic determinants (GP2 epitope II: aa 40-51, ASPSHVGWWSFA; GP3 epitope I: aa 61-72, QAAAEAYEPGRS; GP5 epitope I: aa 35-46, SSSNLQLIYNLT; and GP5 epitope IV: aa 187-200, TPVTRVSAEQWGRP). We demonstrated that all chimeric viruses were stable and infectious in vitro and three chimeric viruses were infectious in vivo. An immunogenicity study in pigs revealed that PCV1-VR2385EPI chimeric viruses elicited neutralizing antibodies against PRRSV-VR2385. The results have important implications for further evaluating PCV1 as a potential vaccine delivery vector.
Copyright © 2015. Published by Elsevier B.V.

KEYWORDS: 

Antigenic epitopes; Porcine circovirus type 1 (PCV1); Porcine circovirus type 2 (PCV2); Porcine reproductive and respiratory syndrome virus (PRRSV); Vaccine delivery vector
PMID:
 
26555162
 
[PubMed - as supplied by publisher]

Tuesday, November 10, 2015

Serum inoculation for elimination of PRRS from a farrow-to-finish farm

 2015 Sep;63(3):389-399.

Serum inoculation as a possibility for elimination of porcine reproductive and respiratory syndrome (PRRS) from a farrow-to-finish pig farm.

Author information

  • 1Institute for the Health Care of Pigs, University of Ljubljana , Gerbičeva 60, 1000 Ljubljana , Slovenia.
  • 2Institute for Microbiology and Parasitology, Veterinary Faculty, University of Ljubljana , Gerbičeva 60, 1000 Ljubljana , Slovenia.

Abstract

The large heterogeneity among porcine reproductive and respiratory syndrome virus (PRRSV) isolates is probably the main obstacle to its effective control using current commercial vaccines. Intentionally exposing all breeding pigs to PRRSV circulating on the farm could eliminate porcine reproductive and respiratory syndrome (PRRS) from the herd. The objective of this study was to eliminate PRRS from a farrow-to-finish pig farm by serum inoculation. The owner was acquainted with the strict biosecurity measures. Breeding pigs were immunised with serum, which was obtained from PRRSV-positive weaners from the same farm. The percent of antibody high positive breeding pigs decreased six months after serum inoculation, while 34 months after serum inoculation no more antibody high positive pigs were detected and 56.8% of breeding pigs and all other categories were free of antibodies. In the breeding herd no virus was detected during all testing while PRRSV circulated in 2-month-old weaners until 12 months after serum inoculation. Later all tested samples from weaners, growers and fatteners were negative. Herd closure and the adoption of strict biosecurity measures are essential. Serum inoculation of the breeding herd proved to be a successful measure for eliminating PRRS from this farrow-to-finish farm.

KEYWORDS: 

PRRS; Porcine; elimination; immunisation; serum inoculation
PMID:
 
26551429
 
[PubMed - as supplied by publisher]

Tuesday, October 27, 2015

High path PRRSv infection, commercial pig production in South Korea

 2015 Oct 24;11(1):272.

Unusual severe cases of type 1 porcine reproductive and respiratory syndrome virus (PRRSV) infection in conventionally reared pigs in South Korea.

Abstract

BACKGROUND: 

Porcine reproductive and respiratory syndrome virus (PRRSV) causes a loss of approximately US$ 70 million every year to the South Korean pork industry. There are two distinct genotypes: European (type 1) and North American (type 2). In South Korea, type 1 and type 2 PRRSV are widely distributed and have evolved continuously since the infection was first described. Here, we present two field cases of type 1 PRRSV infection with unusually severe pathogenicity.

CASE PRESENTATION: 

The first case farm was a two-site production system comprising farrow-to-grower and grower-to-finish units and was historically free from PRRSV infections. The PRRSV vaccine had not been used in both units. In October 2014, pigs in the grower-to-finish unit experienced severe respiratory distress with the mortality rate reaching to 22 %. Despite antibiotic treatment, clinical signs were still noticed in most pigs. The second case farm was also a two-site production system, but had two separate farrow-to-grower units (unit A and unit B). Historically, type 1 PRRSV was continuously present in unit A, but unit B was free from PRRSV. Thus, all grower pigs of unit B were vaccinated before being moved to the grower-to-finish unit. In November 2014, severe respiratory distress was seen in pigs of the grower-to-finish unit. Significant respiratory distress was observed in only the grower herd moved from unit B, and the mortality of those pigs was ~50 %. However, no disease was shown in the grower pigs from unit A.

CONCLUSIONS: 

To our knowledge, the present study is the first observation of the cases of infection by highly pathogenic type 1 PRRSV in South Korea. The Korean type 1 PRRSV strains have undergone unique evolutionary dynamics for the last decade in this country. Although there are known to be three clusters of Korean type 1 PRRSV, their pathogenicity could not be categorized owing to their high level of genetic diversity. Therefore, further studies are needed to demonstrate the novel classification of Korean type 1 PRRSV strains according to their virulence factors.
PMID:
 
26497589
 
[PubMed - as supplied by publisher] 

Wednesday, October 21, 2015

Comparison between the 2013-2014 and 2009-2012 annual USA PRRSv epidemics

 2015 Oct;56(10):1087-9.

Comparison between the 2013-2014 and 2009-2012 annual porcine reproductive and respiratory syndrome virus epidemics in a cohort of sow herds in the United States.

Abstract

The purpose of this study was to describe the 2013/2014 porcine reproductive and respiratory syndrome virus (PRRSV) epidemic in the United States and compare it with the previous 4 y of data from 2009 to 2012. A total of 371 herds participated in the study, representing nearly 1.2 million sows in 15 States. There were significantly fewer PRRSV cases during this study period and the onset of the annual epidemic was delayed approximately 3 wk. Cluster analysis revealed a pattern similar to previous years. The roles of spurious observations, increased awareness of PRRSV epidemics, and porcine epidemic diarrhea virus detection in the United States swine herd are considered. 
PMID:
 
26483586
 
[PubMed - in process] 

Tuesday, October 20, 2015

Network model to simulate regional transmission of PRRSv

 2015 Sep 21. pii: S0378-1135(15)30028-6. doi: 10.1016/j.vetmic.2015.09.010. [Epub ahead of print]
Development of a network based model to simulate the between-farm transmission of the porcine reproductive and respiratory syndrome virus.

Abstract

Contact structure within a population can significantly affect the outcomes of infectious disease spread models. The objective of this study was to develop a network based simulation model for the between-farm spread of porcine reproductive and respiratory syndrome virus to assess the impact of contact structure on between-farm transmission of PRRS virus. For these farm level models, a hypothetical population of 500 swine farms following a multistage production system was used. The contact rates between farms were based on a study analyzing movement of pigs in Canada, while disease spread parameters were extracted from published literature. Eighteen distinct scenarios were designed and simulated by varying the mode of transmission (direct versus direct and indirect contact), type of index herd (farrowing, nursery and finishing), and the presumed network structures among swine farms (random, scale-free and small-world). PRRS virus was seeded in a randomly selected farm and 500 iterations of each scenario were simulated for 52 weeks. The median epidemic size by the end of the simulated period and percentage die-out for each scenario, were the key outcomes captured. Scenarios with scale-free network models resulted in the largest epidemic sizes, while scenarios with random and small-world network models resulted in smaller and similar epidemic sizes. Similarly, stochastic die-out percentage was least for scenarios with scale-free networks followed by random and small-world networks. Findings of the study indicated that incorporating network structures among the swine farms had a considerable impact on the spread of PRRS virus, highlighting the importance of understanding and incorporating realistic contact structures when developing infectious disease spread models for similar populations.
Copyright © 2015 Elsevier B.V. All rights reserved.

KEYWORDS: 

AnyLogic; Between-farm; Infectious diseases; Network model; PRRS virus; Porcine reproductive and respiratory syndrome virus; Swine
PMID:
 
26464321
 
[PubMed - as supplied by publisher]

Friday, October 2, 2015

Descriptive analysis and spatial epidemiology of PRRS for sites in Ontario ARC&E

Thursday, October 1, 2015

Efficacy of M.hp and/or PRRSv vaccination in dually infected pigs

Vet Microbiol. 2015 Sep 21. pii: S0378-1135(15)30033-X. doi: 10.1016/j.vetmic.2015.09.015. [Epub ahead of print]

Efficacy of combined vaccination against Mycoplasma hyopneumoniae and porcine reproductive and respiratory syndrome virus in dually infected pigs

Abstract

Porcine respiratory disease complex (PRDC) is one of the main causes of economic losses for swine producers. This complex is due to a combination of different pathogens and their interactions. Two major pathogens involved in PRDC are Mycoplasma hyopneumoniae (Mhp) and porcine reproductive and respiratory syndrome virus (PRRSV). The objectives of this study were (i) to develop an experimental model of dual Mhp/PRRSV infection in SPF pigs with European strains of Mhp and PRRSV and (ii) to assess and compare the effects of single Mhp, single PRRSV or combined Mhp/PRRSV vaccination against this dual infection. Pigs dually infected with Mhp and PRRSV showed a combination of symptoms characteristic of each pathogen but no significant exacerbation of pathogenicity. Thus, the co-infected pigs displayed coughing and pneumonia typical of Mhp infection in addition to PRRSV-related hyperthermia and decrease in average daily gain (ADG). Hyperthermia was reduced in PRRSV vaccinated animals (single or combined vaccination), whereas ADG was restored in Mhp/PRRSV vaccinated pigs only. Regarding respiratory symptoms and lung lesions, no vaccine decreased coughing. However, all vaccines reduced the pneumonia score but more so in animals receiving the Mhp vaccine, whether single or combined. This vaccine also decreased the Mhp load in the respiratory tract. In conclusion, combined vaccination against both Mhp and PRRSV efficiently pooled the efficacy of each single PRRSV and Mhp vaccination and could be an interesting tool to control PRDC in European swine production.
Copyright © 2015 Elsevier B.V. All rights reserved.

KEYWORDS:

Dual infection; European strain; Mycoplasma hyopneumoniae; PRDC; PRRS; Vaccine
PMID: 26422712 [PubMed - as supplied by publisher]